Wilbrink Rick, van der Weele Linda, Spoorenberg Anneke J P L, de Vries Niek, Niewold Ilse T G, Verstappen Gwenny M, Kroese Frans G M
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Department of Rheumatology & Clinical Immunology, Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Eur J Immunol. 2025 Feb;55(2):e202451398. doi: 10.1002/eji.202451398. Epub 2024 Dec 20.
B cells with low or absent expression of CD21 (CD21 B cells) gained attention due to their expansion in the peripheral blood of patients with immune-mediated, rheumatic diseases. This is not only observed in typical autoimmune diseases like systemic lupus erythematosus and Sjögren's disease (SjD) but also in radiographic axial spondyloarthritis (r-axSpA), which is considered an autoinflammatory disease. To gain more insight into the origins of the heterogeneous CD21 B-cell population, and its relation to the plasmablast (PB) compartment, we profiled the B-cell-receptor (BCR) repertoire in CD27 and CD27 fractions of CD21 B cells and early PBs using next-generation sequencing. Populations were sorted from peripheral blood of healthy individuals, SjD patients, and r-axSpA patients (n = 10 for each group). In healthy individuals and both patient groups, our findings indicate that CD27CD21 B cells, which exhibit few mutations in their BCR, may develop into CD27CD21 B cells and PBs, both marked by considerably more mutations. Given the known expansion of circulating CD27CD21 B cells in SjD and r-axSpA patients and clonal relationships with both CD27CD21 B cells and early PBs, these cells might actively contribute to (pathological) immune responses in rheumatic diseases with autoimmune and/or autoinflammatory characteristics.
CD21表达低或缺失的B细胞(CD21 B细胞)因其在免疫介导的风湿性疾病患者外周血中的扩增而受到关注。这不仅在系统性红斑狼疮和干燥综合征(SjD)等典型自身免疫性疾病中观察到,在被认为是自身炎症性疾病的放射学轴性脊柱关节炎(r-axSpA)中也有发现。为了更深入了解异质性CD21 B细胞群体的起源及其与浆母细胞(PB)区室的关系,我们使用下一代测序技术分析了CD21 B细胞和早期PB的CD27⁺和CD27⁻亚群中的B细胞受体(BCR)库。细胞群体从健康个体、SjD患者和r-axSpA患者的外周血中分选出来(每组n = 10)。在健康个体和两个患者组中,我们的研究结果表明,其BCR中突变较少的CD27⁻CD21 B细胞可能会发育为CD27⁺CD21 B细胞和PB,这两者的特征都是突变明显更多。鉴于在SjD和r-axSpA患者中循环CD27⁻CD21 B细胞的已知扩增以及与CD27⁺CD21 B细胞和早期PB的克隆关系,这些细胞可能在具有自身免疫和/或自身炎症特征的风湿性疾病中积极参与(病理)免疫反应。